Leonard Rickey Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,840
Closed -$295K 69
2020
Q2
$295K Buy
3,840
+34
+0.9% +$2.61K 0.19% 45
2020
Q1
$285K Buy
3,806
+204
+6% +$14.1K 0.22% 41
2019
Q4
$234K Buy
3,602
+138
+4% +$8.99K 0.14% 72
2019
Q3
$220K Sell
3,464
-117
-3% -$7.65K 0.15% 70
2019
Q2
$242K Sell
3,581
-80
-2% -$5.26K 0.16% 64
2019
Q1
$238K Sell
3,661
-62
-2% -$4.12K 0.17% 62
2018
Q4
$233K Sell
3,723
-110
-3% -$7.69K 0.19% 58
2018
Q3
$296K Buy
3,833
+6
+0.2% +$453 0.22% 51
2018
Q2
$271K Buy
3,827
+6
+0.2% +$424 0.2% 52
2018
Q1
$288K Sell
3,821
-121
-3% -$9.62K 0.22% 48
2017
Q4
$282K Buy
+3,942
New +$299K 0.22% 51

Other funds holding GILD

Leonard Rickey Investment Advisors's GILD Position: Q3 2020 in Review

Leonard Rickey Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,840 shares — an estimated $295K sold.

Leonard Rickey Investment Advisors first reported a position in GILD in Q4 2017 and held it in 11 quarters. The position peaked at $296K in Q3 2018. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Leonard Rickey Investment Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Leonard Rickey Investment Advisors sold 3,840 Gilead Sciences shares in Q3 2020, an estimated $295K.
  • Leonard Rickey Investment Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 11 quarters.
  • Leonard Rickey Investment Advisors's Gilead Sciences position peaked at $296K in Q3 2018.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Leonard Rickey Investment Advisors's 13F filing for Q3 2020, filed 16 Oct 2020.